Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
Launched by FOUNDATION FOR SARCOIDOSIS RESEARCH · Jan 29, 2024
Trial Information
Current as of November 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry) is a study aimed at understanding sarcoidosis, a condition that causes inflammation in various parts of the body. This study invites people diagnosed with sarcoidosis to share their experiences, including their symptoms, how they were diagnosed, the treatments they have received, and how the disease affects their daily lives. The goal is to gather important information over time to help researchers better understand this condition and address the needs of the sarcoidosis community.
To participate in this study, you need to be an English speaker and have a diagnosis of sarcoidosis. There are no age limits, and anyone can join regardless of gender. If you choose to participate, you will be asked to provide information about your health and experiences, all while ensuring your privacy is protected. This is a great opportunity to contribute to research that could lead to better care and support for others living with sarcoidosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. English speaking
- • 2. Consent
- • 3. Sarcoidosi diagnosis -
- Exclusion Criteria:
- • NONE
About Foundation For Sarcoidosis Research
The Foundation for Sarcoidosis Research (FSR) is a leading nonprofit organization dedicated to advancing the understanding, diagnosis, and treatment of sarcoidosis through innovative research and education. Committed to improving the quality of life for individuals affected by this complex inflammatory disease, FSR collaborates with researchers, healthcare professionals, and patients to foster groundbreaking clinical trials and initiatives. By funding research projects, disseminating critical information, and advocating for patient-centered care, the Foundation plays a pivotal role in transforming the landscape of sarcoidosis management and enhancing outcomes for those impacted by the condition.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported